Stryker (SYK) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Stryker Revenue Highlights


Latest Revenue (Y)

$20.50B

Latest Revenue (Q)

$5.49B

Main Segment (Y)

MedSurg

Main Geography (Y)

EMEA

Stryker Revenue by Period


Stryker Revenue by Year

DateRevenueChange
2023-12-31$20.50B11.11%
2022-12-31$18.45B7.84%
2021-12-31$17.11B19.21%
2020-12-31$14.35B-3.58%
2019-12-31$14.88B9.43%
2018-12-31$13.60B9.30%
2017-12-31$12.44B9.88%
2016-12-31$11.32B13.86%
2015-12-31$9.95B2.80%
2014-12-31$9.68B7.25%
2013-12-31$9.02B4.20%
2012-12-31$8.66B4.21%
2011-12-31$8.31B13.48%
2010-12-31$7.32B8.88%
2009-12-31$6.72B0.07%
2008-12-31$6.72B11.96%
2007-12-31$6.00B11.01%
2006-12-31$5.41B10.96%
2005-12-31$4.87B14.29%
2004-12-31$4.26B17.57%
2003-12-31$3.63B20.38%
2002-12-31$3.01B15.73%
2001-12-31$2.60B13.67%
2000-12-31$2.29B8.83%
1999-12-31$2.10B90.69%
1998-12-31$1.10B12.56%
1997-12-31$980.10M7.69%
1996-12-31$910.10M4.37%
1995-12-31$872.00M27.88%
1994-12-31$681.90M22.36%
1993-12-31$557.30M-

Stryker generated $20.50B in revenue during NA 2023, up 11.11% compared to the previous quarter, and up 150.71% compared to the same period a year ago.

Stryker Revenue by Quarter

DateRevenueChange
2024-09-30$5.49B1.33%
2024-06-30$5.42B3.41%
2024-03-31$5.24B-9.84%
2023-12-31$5.82B18.46%
2023-09-30$4.91B-1.74%
2023-06-30$5.00B4.56%
2023-03-31$4.78B-8.15%
2022-12-31$5.20B16.14%
2022-09-30$4.48B-0.31%
2022-06-30$4.49B5.10%
2022-03-31$4.28B-9.06%
2021-12-31$4.70B13.00%
2021-09-30$4.16B-3.12%
2021-06-30$4.29B8.63%
2021-03-31$3.95B-7.25%
2020-12-31$4.26B14.05%
2020-09-30$3.74B35.20%
2020-06-30$2.76B-22.97%
2020-03-31$3.59B-13.14%
2019-12-31$4.13B15.17%
2019-09-30$3.59B-1.73%
2019-06-30$3.65B3.81%
2019-03-31$3.52B-7.38%
2018-12-31$3.80B17.09%
2018-09-30$3.24B-2.41%
2018-06-30$3.32B2.50%
2018-03-31$3.24B-6.63%
2017-12-31$3.47B15.47%
2017-09-30$3.01B-0.20%
2017-06-30$3.01B1.93%
2017-03-31$2.96B-6.40%
2016-12-31$3.16B11.44%
2016-09-30$2.83B-0.25%
2016-06-30$2.84B13.83%
2016-03-31$2.50B-8.10%
2015-12-31$2.71B12.19%
2015-09-30$2.42B-0.49%
2015-06-30$2.43B2.23%
2015-03-31$2.38B-9.13%
2014-12-31$2.62B9.59%
2014-09-30$2.39B1.10%
2014-06-30$2.36B2.52%
2014-03-31$2.31B-6.60%
2013-12-31$2.47B14.74%
2013-09-30$2.15B-2.76%
2013-06-30$2.21B1.00%
2013-03-31$2.19B-6.33%
2012-12-31$2.34B13.94%
2012-09-30$2.05B-2.56%
2012-06-30$2.11B-2.55%
2012-03-31$2.16B-2.44%
2011-12-31$2.21B9.06%
2011-09-30$2.03B-0.71%
2011-06-30$2.05B1.50%
2011-03-31$2.02B1.01%
2010-12-31$2.00B12.87%
2010-09-30$1.77B0.53%
2010-06-30$1.76B-2.27%
2010-03-31$1.80B-1.91%
2009-12-31$1.83B10.94%
2009-09-30$1.65B1.16%
2009-06-30$1.63B2.06%
2009-03-31$1.60B-6.80%
2008-12-31$1.72B3.94%
2008-09-30$1.65B-3.48%
2008-06-30$1.71B4.78%
2008-03-31$1.63B-

Stryker generated $5.49B in revenue during Q3 2024, up 1.33% compared to the previous quarter, and up 109.97% compared to the same period a year ago.

Stryker Revenue Breakdown


Stryker Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Orthopaedics and Spine$8.66B$2.81B$2.66B--
MedSurg$11.84B$250.00M$286.00M--
MedSurg and Neurotechnology-$302.00M$277.00M--
Neurotechnology And Spine---$1.05B$1.08B
Orthopaedics---$4.96B$5.25B

Stryker's latest annual revenue breakdown by segment (product or service), as of Dec 23: MedSurg (57.74%), and Orthopaedics and Spine (42.26%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18
Orthopaedics and Spine$2.27B$2.31B$2.24B$2.39B$2.15B$1.89B$1.94B$1.85B------------
MedSurg$3.22B$3.12B$3.00B$3.43B$1.75B$1.75B$1.62B$1.85B$1.60B$1.32B$1.62B$1.84B$1.58B$1.62B$1.54B$1.72B----
MedSurg and Neurotechnology----$3.05B$2.59B$2.55B$2.42B------------
Orthopaedics--------$1.53B$1.63B$1.48B$1.53B$1.32B$894.00M$1.22B$1.47B$1.26B$1.27B$1.25B$1.38B
Neurotechnology And Spine--------$876.00M$918.00M$848.00M$882.00M$820.00M$546.00M$744.00M$827.00M$749.00M$760.00M$722.00M$700.00M

Stryker's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: MedSurg (58.68%), and Orthopaedics and Spine (41.32%).

Stryker Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
EMEA$2.62B$2.35B$2.30B$1.82B$1.89B
Asia Pacific$1.95B$1.89B$1.97B$1.63B$1.62B
Other foreign countries$677.00M$578.00M$515.00M$448.00M$422.00M

Stryker's latest annual revenue breakdown by geography, as of Dec 23: EMEA (49.95%), Asia Pacific (37.13%), and Other foreign countries (12.92%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Sep 23Jun 23Dec 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18
Non-US$1.39B$1.38B$1.33B$1.23B$1.28B$1.28B--------------
MedSurg and Neurotechnology-----$3.05B--------------
Orthopaedics and Spine-----$2.15B--------------
UNITED STATES------$3.42B-------------
MedSurg-------$69.00M$73.00M$61.00M$69.00M$66.00M$48.00M$67.00M$74.00M$72.00M$75.00M$65.00M$69.00M$66.00M
Orthopaedics-------$639.00M$674.00M$640.00M$1.53B$430.00M$330.00M$392.00M$1.47B$407.00M$394.00M$396.00M$1.38B$376.00M

Stryker's latest quarterly revenue breakdown by geography, as of Sep 24: Non-US (100.00%).

Stryker Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ABTAbbott Laboratories$40.11B$10.63B
MDTMedtronic$32.36B$7.92B
SYKStryker$20.50B$5.49B
EWEdwards Lifesciences$6.00B$1.39B
SNNSmith & Nephew$5.55B$2.79B
STESTERIS$5.14B$1.28B
DXCMDexCom$3.62B$994.20M
ZBHZimmer Biomet$1.94B$143.40M
ZIMVZimVie$457.43M$103.22M

SYK Revenue FAQ


Stryker's yearly revenue for 2023 was $20.5B, representing an increase of 11.11% compared to 2022. The company's yearly revenue for 2022 was $18.45B, representing an increase of 7.84% compared to 2021. SYK's yearly revenue for 2021 was $17.11B, representing an increase of 19.21% compared to 2020.

Stryker's quarterly revenue for Q3 2024 was $5.49B, a 1.33% increase from the previous quarter (Q2 2024), and a 11.92% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $5.42B, a 3.41% increase from the previous quarter (Q1 2024), and a 8.53% increase year-over-year (Q2 2023). SYK's quarterly revenue for Q1 2024 was $5.24B, a -9.84% decrease from the previous quarter (Q4 2023), and a 9.73% increase year-over-year (Q1 2023).

Stryker's revenue growth rate for the last 3 years (2021-2023) was 19.82%, and for the last 5 years (2019-2023) was 37.72%.

Stryker's revenue streams in c 23 are Orthopaedics and Spine, and MedSurg. Orthopaedics and Spine generated $8.66B in revenue, accounting 42.26% of the company's total revenue, up 208.59% year-over-year. MedSurg generated $11.84B in revenue, accounting 57.74% of the company's total revenue, up 4634.40% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Stryker was MedSurg. This segment made a revenue of $11.84B, representing 57.74% of the company's total revenue.